Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chloe S Chaudhury"'
Autor:
Kodye L. Abbott, Julia M. Salamat, Patrick C. Flannery, Chloe S. Chaudhury, Aneesh Chandran, Saraswathi Vishveshwara, Sridhar Mani, Jianfeng Huang, Amit K. Tiwari, Satyanarayana R. Pondugula
Publikováno v:
ACS Omega. 7:34034-34044
During multidrug combination chemotherapy, activation of the nuclear receptor and the transcription factor human pregnane xenobiotic receptor (hPXR) has been shown to play a role in the development of chemoresistance. Mechanistically, this could occu
Autor:
Sridhar Mani, Karolina Poulikova, Saraswathi Vishveshwara, Satyanarayana R. Pondugula, Zdenek Dvorak, Kodye L. Abbott, Eva Jiskrova, Barbora Vyhlidalova, Aneesh Chandran, Chloe S. Chaudhury
Publikováno v:
Molecular Pharmacology. 95:324-334
Activation of human pregnane X receptor (hPXR) has been associated with induction of chemoresistance. It has been proposed that such chemoresistance via cytochrome P450/drug transporters can be reversed with the use of antagonists that specifically a
Autor:
Kush Fansiwala, Babak Tofighi, Ipsita Subudhi, Daniel Schatz, Noa Krawczyk, Dalia Walzer, Chloe S Chaudhury, Jennifer McNeely, Adam R. Demner, Timothy Reed
Publikováno v:
Journal of Addiction Medicine
OBJECTIVES: The purpose of this study was to assess the feasibility and clinical impact of telemedicine-based opioid treatment with buprenorphine-naloxone following the Coronavirus disease 2019 pandemic. METHODS: Participants included in this retrosp
Autor:
Caryn G. Morse, Colleen Hadigan, Julia B. Purdy, Chia-Ying Liu, David E. Kleiner, Chloe S. Chaudhury, Takara L. Stanley
Publikováno v:
Liver International. 38:797-802
BACKGROUND & AIMS Non-alcoholic fatty liver disease is common in human immunodeficiency virus, but there are no approved therapies. The aim of this open-label proof-of-concept study was to determine the effect of the mineralocorticoid receptor antago
Autor:
Sarah Kattakuzhy, Julia Sheehan, Elizabeth Akoth, Elana Rosenthal, Colleen Hadigan, Chloe Gross, Shyam Kottilil, Henry Masur, Rachel Silk, Cheryl Chairez, Chloe S. Chaudhury
Publikováno v:
The Journal of Infectious Diseases. 217:47-50
Hepatitis C clearance with directly acting antivirals (DAAs) may be associated with acute decreases in hemoglobin A1c (HbA1c). We prospectively evaluated 251 chronic hepatitis C virus (HCV)-infected subjects (31% human immunodeficiency virus [HIV] po
Autor:
Thomas Mee, Chloe S. Chaudhury, Colleen Hadigan, Julia Aepfelbacher, Karyn Hawkins, Nicola Dee, Julia B. Purdy, Kara-anne Curl
Publikováno v:
AIDS care. 32(3)
Reproductive and sexual health outcomes of adults with perinatal human immunodeficiency virus (PHIV) have not been well-characterized. This prospective cross-sectional study of 35 adult persons living with HIV (PLWH) from early life and 20 matched HI
Autor:
Mary Ann McLaughlin, Elana Rosenthal, Sarah Kattakuzhy, Rachel Silk, Julia B Balmaceda, Cheryl Chairez, Olivia Belliveau, Chloe S. Chaudhury, Colleen Hadigan, David E. Kleiner, Julia Aepfelbacher, Shyam Kottilil, Chloe Gross
Publikováno v:
Antivir Ther
Background While acute changes in hepatic fibrosis are recognized shortly after achieving sustained virological response (SVR) using direct-acting antiviral therapies, long-term outcomes for the growing population of successfully treated patients wit
Autor:
Aneesh Chandran, Satyanarayana R. Pondugula, Patrick C. Flannery, Sridhar Mani, Natasha Narayanan, Chloe S. Chaudhury, Saraswathi Vishveshwara, Julia M. Salamat, Kodye L. Abbott
Publikováno v:
The FASEB Journal. 34:1-1
Publikováno v:
The FASEB Journal. 32
Autor:
Sarah Kattakuzhy, Elana Rosenthal, Chloe Gross, Mary M. McLaughlin, Takara L. Stanley, Chloe S Chaudhury, Cheryl Chairez, Shyam Kottilil, Rachel Silk, Colleen Hadigan, Thomas Mee
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 69(4)
Background Hepatitis C virus (HCV) and hepatic dysfunction are associated with low total and free testosterone (TT and FT) and high sex hormone-binding globulin (SHBG). However, little is known about changes in testosterone following successful HCV t